← Back to Search

1 for Osteoporosis (ROCKET Trial)

N/A
Waitlist Available
Led By Susan B Jaglal PhD
Research Sponsored by Ontario Ministry of Health and Long Term Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1.5 years
Awards & highlights

ROCKET Trial Summary

A Regional Osteoporosis Coordinator located at Women's College Hospital will follow-up with low trauma fracture patients from 30 smaller community hospitals across Ontario. To evaluate whether this quality improvement program can increase post-fracture osteoporosis care in these individuals, hospitals will be randomized to receive osteoporosis specific recommendations or falls prevention advice. Patients will be asked to complete two short telephone surveys about their recent fracture, risk factors, osteoporosis knowledge and diagnostic and treatment history. All patients in the falls prevention advice group will receive the osteoporosis specific recommendations 6 months after their fracture.

Eligible Conditions
  • Osteoporosis
  • Fragility Fractures

ROCKET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
proportion of patients from the intervention group as compared to the control group that had "appropriate management" based on a composite of undergoing a BMD test and starting therapy within 6 months of fracture.
Secondary outcome measures
Osteoporosis
participants' experience and perceptions of future fracture risk; their understanding of the educational materials and acceptance of recommended treatment plans.

ROCKET Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
hospitals randomly allocated to receive physician and patient osteoporosis recommendations from the regional coordinator
Group II: 2Active Control1 Intervention
hospitals randomly allocated to receive falls prevention advice

Find a Location

Who is running the clinical trial?

Ontario Ministry of Health and Long Term CareLead Sponsor
91 Previous Clinical Trials
107,724 Total Patients Enrolled
Susan B Jaglal PhDPrincipal InvestigatorToronto Rehabilitation Institute, University of Toronto
Oana S Donescu MD PhDStudy DirectorToronto Rehabilitation Institute, University of Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Osteoporosis Coordinator for Low Volume Community Hospitals
2007. "Osteoporosis Coordinator for Low Volume Community Hospitals". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00511693.
All > Osteoporosis
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top